| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
AGL
Agilon Health
|
Aug 06, 2026 | HOLD |
Hold
-52.6% avg upside
26 analysts
|
— | · | · |
|
STLN
Starling Oncology Institute
|
Aug 03, 2026 | BUY |
Strong Buy
+25.8% avg upside
7 analysts
|
$7.00
39.09% Upside
|
+0.0% | · |
|
ASTH
Astrana Health
|
May 08, 2026 | BUY |
Strong Buy
+57.0% avg upside
16 analysts
|
$41.00
14.38% Upside
|
-9.2% | · |
|
EVH
Evolent Health
|
May 07, 2026 | BUY |
Strong Buy
+223.2% avg upside
19 analysts
|
$5.00
62.43% Upside
|
-15.0% | · |
|
PRVA
Privia Health Group
|
May 07, 2026 | BUY |
Strong Buy
+32.7% avg upside
26 analysts
|
$30.00
25.28% Upside
|
-0.1% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.